Kiora Pharmaceuticals Released Preclinical Data Showing That KIO-300 Significantly Suppressed Seizure-associated Electrophysiological Activity In An Ex Vivo Temporal Lobe Epilepsy Model

뉴스 본문을 불러오고 있어요.

Kiora Pharmaceuticals Released Preclinical Data Showing That KIO-300 Significantly Suppressed Seizure-associated Electrophysiological Activity In An Ex Vivo Temporal Lobe Epilepsy Model | 웨이프 WAPE

Kiora Pharmaceuticals Released Preclinical Data Showing That KIO-300 Significantly Suppressed Seizure-associated Electrophysiological Activity In An Ex Vivo Temporal Lobe Epilepsy Model

기사 요약

관련 종목

댓글 —